160 related articles for article (PubMed ID: 28966482)
41. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
[TBL] [Abstract][Full Text] [Related]
42. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
[TBL] [Abstract][Full Text] [Related]
43. An observational cohort study of bronchoalveolar lavage fluid galactomannan and
Gao CA; Markov NS; Pickens C; Pawlowski A; Kang M; Walter JM; Singer BD; Wunderink RG
medRxiv; 2024 Feb; ():. PubMed ID: 38370841
[TBL] [Abstract][Full Text] [Related]
44. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
[TBL] [Abstract][Full Text] [Related]
45. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
Brownback KR; Pitts LR; Simpson SQ
Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
[TBL] [Abstract][Full Text] [Related]
46. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
[TBL] [Abstract][Full Text] [Related]
47. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
[TBL] [Abstract][Full Text] [Related]
48. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
49. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
50. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
He H; Ding L; Sun B; Li F; Zhan Q
Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
[TBL] [Abstract][Full Text] [Related]
51. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis.
Khodavaisy S; Hedayati MT; Alialy M; Habibi MR; Badali H
Curr Med Mycol; 2015 Mar; 1(1):12-17. PubMed ID: 28680975
[TBL] [Abstract][Full Text] [Related]
52. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
Fortún J; Martín-Dávila P; Gomez Garcia de la Pedrosa E; Silva JT; Garcia-Rodríguez J; Benito D; Venanzi E; Castaño F; Fernández-Ruiz M; Lazaro F; García-Luján R; Quiles I; Cabanillas JJ; Moreno S; Aguado JM
J Infect; 2016 Jun; 72(6):738-744. PubMed ID: 27025205
[TBL] [Abstract][Full Text] [Related]
53. Comparative performance of the Platelia
Albert E; Alcaraz MJ; Giménez E; Clari MÁ; Torres I; Colomina J; Olea B; Tormo M; Piñana JL; Oltra R; Signes-Costa J; Carbonell N; Solano C; Navarro D
Microbiol Spectr; 2024 Jun; ():e0391023. PubMed ID: 38916338
[TBL] [Abstract][Full Text] [Related]
54. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
55. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
[TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
57. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis.
Linder KA; Kauffman CA; Zhou S; Miceli MH
Mycoses; 2019 Dec; 62(12):1189-1193. PubMed ID: 31581342
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients.
Wu Z; Wang L; Tan L; Wu J; Chen Z; Hu M
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115274. PubMed ID: 33453546
[TBL] [Abstract][Full Text] [Related]
59. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
Desai R; Ross LA; Hoffman JA
Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
